Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avalo Therapeutics Inc AVTX

Healthcare Biotechnology
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the treatment of immune dysregulation by developing therapies that target the Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes (LIGHT)-signaling network. Its clinical-stage... see more

Bullboard (NDAQ:AVTX)

View:
User Avatar Image
(22)
•••
  • GeneralWolfeX
Post by GeneralWolfeon Sep 15, 2023 12:38pm

Get in while you can...

unless this company is going bankrupt, this is dirt cheap right now......buy, buy, buy....
30
User Avatar Image
(3)
•••
  • NibinatorX
Post by Nibinatoron Aug 20, 2023 8:05pm

Allez on y croit plus que jamais

Regarder moi tout ce volume allez pump and dump
51

Unlocking the Future: Metals Co. Unveils Positive Pre-Feasibility Study for the Turnagain Nickel-Cobalt Deposit

posted Sep 22, 2023 9:00am  by  Giga Metals Corp.
“We are very pleased to see the positive Pre-Feasibility Study,” said Kota Ikenishi, General Manager of the Battery Minerals Office, Mitsubishi Corporation. “We see a nickel project like Turnagain with low carbon intensity in a stable jurisdiction has a key role to play in the future of the nickel industry, in particular for the battery industry. We look forward to Turnagain’s potential to be further verified in works ahead.” ...read more
User Avatar Image
(3)
•••
  • NibinatorX
Comment by Nibinatoron Aug 20, 2023 8:03pm

RE:RE:CERC..... Volume is increasing

Le volume reste etonnant a 0.12
11
Comment by Joe455on Apr 02, 2022 6:29pm

RE:CERC..... Volume is increasing

up 20%!
37
User Avatar Image
(81)
•••
  • IseneschalX
Post by Iseneschalon May 11, 2021 1:58pm

CERC..... Volume is increasing

Roughly ~ 35k per 1 minute Not bad
133
User Avatar Image
(81)
•••
  • IseneschalX
Comment by Iseneschalon May 11, 2021 1:43pm

RE:CERC.....might have a chance here

 A break of the $2.64 could be a break out ....just an observation
76
User Avatar Image
(81)
•••
  • IseneschalX
Post by Iseneschalon May 11, 2021 12:33pm

CERC.....might have a chance here

me .....no position
130
User Avatar Image
(81)
•••
  • IseneschalX
Post by Iseneschalon May 11, 2021 11:47am

CERC.... Dang

Stopped out THat's it.... done
92

Thematica Insights Report and Investor Guide

Thematica: Battery Metals Report

Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Jeff Nielson
22 September 2023 09:28
User Avatar Image
(81)
•••
  • IseneschalX
Post by Iseneschalon May 11, 2021 11:44am

CERC...... adding here on the good news

$2.60
90
User Avatar Image
(81)
•••
  • IseneschalX
Post by Iseneschalon May 11, 2021 10:08am

CERC...... trying some here on

The "pullback" ....... $2.85 FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19
88